Noradrenergic Activity, Cognition and Major Depressive Disorder
NCT02470026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131
Last updated 2019-05-23
Summary
This study investigates influences of nordadrenergic activity on cognition in patients with major depression regarding influences of early life stress.
Conditions
- Major Depressive Disorder
- Early Life Trauma
Interventions
- DRUG
-
yohimbine
single low dose treatment
- DRUG
-
single control treatment
Sponsors & Collaborators
-
Charite University, Berlin, Germany
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2017-11-30
- Completion
- 2018-10-31
Countries
- Germany
Study Locations
More Related Trials
-
Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging
NCT01831440 ·Status: UNKNOWN ·Phase: NA
-
Pharmacologic Treatment Augmentation in Chronic Depression
NCT06410599 ·Status: RECRUITING ·Phase: PHASE2
-
Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
NCT05909267 ·Status: RECRUITING ·Phase: NA
-
Cognitive Rehabilitation in Patients With Depression
NCT03338413 ·Status: UNKNOWN ·Phase: NA
-
PRediction Of Treatment Response to ECT in Depression and Cognitive Side effecTs
NCT02562846 ·Status: COMPLETED
-
Depressed Mood Improvement Through Nicotine Dosing 2
NCT04433767 ·Status: COMPLETED ·Phase: PHASE2
-
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
NCT07009223 ·Status: RECRUITING ·Phase: NA
-
Functional and Metabolic Changes in the Course of Antidepressive Treatment
NCT02099630 ·Status: COMPLETED
-
Neural Mechanism Underlying Social Cognition in Depressive Patients
NCT03413670 ·Status: UNKNOWN
-
Study of Cognitive Inhibition Disorders in Depressed Older Suicide Attempters
NCT01333215 ·Status: UNKNOWN
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
Neurophysiological Markers in the Depressive Episode Characterized by Anhedonic Drug Resistance: Evaluation of Motor Skills and P300 Wave
NCT04456868 ·Status: TERMINATED ·Phase: NA
-
Modafinil's Effects on Cognition in Remitted MDD
NCT03620253 ·Status: TERMINATED ·Phase: PHASE3
-
Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
NCT00744406 ·Status: COMPLETED ·Phase: PHASE2
-
Prucalopride and Cognition in Recovered Depression
NCT05220228 ·Status: COMPLETED ·Phase: NA
-
Cognitive Training for Depression II
NCT01934491 ·Status: COMPLETED ·Phase: NA
-
A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System
NCT03148522 ·Status: UNKNOWN ·Phase: NA
-
Maintaining Mechanisms of Chronic Depression and Their Changeability
NCT02801513 ·Status: COMPLETED ·Phase: NA
-
Depressed Mood Improvement Through Nicotine Dosing 3
NCT05746273 ·Status: RECRUITING ·Phase: PHASE2
-
Modeling and Predicting Real World Behavior Using Mobile Sensor Data on Patients With Major Depressive Disorder
NCT02499094 ·Status: COMPLETED ·Phase: NA
-
Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?
NCT02938559 ·Status: COMPLETED ·Phase: NA
-
Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale
NCT03872492 ·Status: TERMINATED ·Phase: NA
-
Cognitive Training for Depression
NCT01936506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion
NCT02026622 ·Status: COMPLETED ·Phase: NA
-
Combining Antidepressants and Attention Bias Modification in Depression
NCT05503966 ·Status: RECRUITING ·Phase: NA